| 摘要: |
| 高危型人乳头瘤病毒（HR－HPV）感染是宫颈发生癌变的首要因素，HR-HPV是导致宫颈癌前病变（CIN）和宫颈癌（CC）的主要病因。目前尚没有疗效肯定的抗HR-HPV感染的药物。故对近3年来中医治疗宫颈高危型人乳头瘤病毒感染的文献加以归纳总结，以探索中医治疗宫颈高危型人乳头瘤病毒感染疗效好的方法，从而有效的治疗宫颈HR-HPV感染，阻断感染持续状态，逆转CIN病理改变，并对于预防宫颈癌的发生具有重要意义。 |
| 关键词: 宫颈 人乳头瘤病毒 中医治疗 临床研究进展 |
| DOI：10.11656/j.issn.1673-9043.2018.05.21 |
| 分类号:R271.1 |
| 基金项目:G20工程支撑保障项目资助。 |
|
| Clinical research progress of Chinese medicine treatment of cervical high-risk human papilloma virus infection |
|
WEN Lijuan1, ZHANG Yun1, XUE Xiaoou2
|
|
1.First Clinical Medical school of Beijing University of Chinese Medicine, Beijing 100700, China;2.First Clinical Medical School of Beijing University of Chinese Medicine, Beijing 100700, China
|
| Abstract: |
| High risk human papillomavirus (HR-HPV) infection is a primary factor in cervical carcinogenesis, HR-HPV is the leading cause of cervical precancerous lesions (CIN) and cervical cancer (CC) is the main cause. There is no anti HR-HPV infection drug effect is available. In this paper, for the past ten years, the Chinese medicine treatment of cervical high-risk people HPV infection in the literature to summarize, found that Chinese medicine treatment of cervical high-risk human papilloma virus infection method to find good curative effect, it is an effective treatment for cervical HR-HPV infection, persistent infection blocking state, change the reversal of CIN pathology, is of great significance to occur in the prevention of cervical cancer. |
| Key words: Uterus HPV Chinese traditional treatment Clinical research progress |
